Selected PublicationsB. Fahie, E. Guggenheim, "The Business Challenges of Externalizing R&D." Scientific Computing, Dec. 2015.E. Guggenheim, "Designing an ELE Workspace for Analytical Development." Poster, PittCon, March 2015.E. Guggenheim, "Case study: Reliability vs. flexibility in an Analytical Development testing environment." Presentation, SmartLab Exchange, February 2015.

Selected Publications:J. Olejnik, E. Guggenheim, V. Visalakshi, "Methods and compositions for inhibiting undesired cleaving of labels." U.S. Patent 8623598J. Olejnik, E. Guggenheim, V. Visalakshi, "Methods and solutions for inhibiting undesired cleaving of labels." U.S. Patent 8883999

Selected Publications:G. Church, J. Olejnik, M. Werner, E. Guggenheim, J. DiMeo, M. S. Marma, V. Visalakshi, T. Hagerott, E. Golaski, P. Veatch, D. Stoops, S. Gordon, "Clinical DNA Sequencer for Ultra-Low Cost Testing", Journal of Biomolecular Techniques, 23, S9, 2012.D. Hutter, M.-J. Kim, N. Karalkar, N. A. Leal, F. Chen, E. Guggenheim, V. Visalakshi, J. Olejnik, S. Gordon, S. A. Benner, "Labeled Nucleoside Triphosphates with Reversibly Terminating Aminoalkoxyl Groups." Nucleosides, Nucleotides and Nucleic Acids, 29, 11-12, 879-895, 2010.

Selected Publications:E. R. Guggenheim, D. Xu, C. X. Zhang, P. V. Chang, S. J. Lippard, "Photoaffinity Isolation and Identification of Proteins in Cancer Cell Extracts that Bind to Platinum‐Modified DNA," ChemBioChem, 10, 1, 141-157, 2009.E. R. Guggenheim, A. E. Ondrus, M. Movassaghi, S. J. Lippard, "Poly(ADP-ribose) polymerase-1 activity facilitates the dissociation of nuclear proteins from platinum-modified DNA," Bioorganic & Medicinal Chemistry, 16, 23, 10121-10128, 2008.E. Guggenheim, Presentation, International Symposium on Platinum Coordination Compounds in Cancer Chemotherapy, Verona, Italy, 2007.